Influence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalis

The influence of culture medium of the MICs of eight cephalosporins for 45 strains of Streptococcus faecalis was investigated. The MICs of cephalothin, cefamandole, and cefoperazone were not substantially influenced by the type of culture medium used. In contrast, MICs of cefuroxime, ceftizoxime, cefotaxime, cefmenoxime, and ceftriaxone varied markedly with both the commercial brand and the blood content of the broth used. The use of Mueller-Hinton broths (from Oxoid Ltd., GIBCO Diagnostics, and Difco Laboratories) supplemented with 5% lysed sheep blood frequently resulted in MICs that were greater than or equal to 16 times lower than the MICs obtained with these same broths without blood. Similar, but less marked, patterns were observed when supplemented and unsupplemented brain heart infusion and Sceptor broths were used. The influence of the broth on MICs suggests a complex interaction between some cephalosporins, medium components, and organisms. The cephalosporins that were affected by media share an identical moiety at the 7-acyl position (cefuroxime is slightly different), but this structure is not shared by those cephalosporins that were not affected. This commonality in structure at the 7-acyl position may be partially responsible for the observed results.

[1]  R. Jones,et al.  Medium-dependent zone size discrepancies associated with susceptibility testing of group D streptococci against various cephalosporins , 1983, Journal of clinical microbiology.

[2]  R. Jones,et al.  Antimicrobial activity of desacetylcefotaxime alone and in combination with cefotaxime: evidence of synergy. , 1982, Reviews of infectious diseases.

[3]  H. Neu Antibacterial activity of desacetylcefotaxime alone and in combination with cefotaxime. , 1982, Reviews of infectious diseases.

[4]  R. Jones,et al.  Cefotaxime: a review of in vitro antimicrobial properties and spectrum of activity. , 1982, Reviews of infectious diseases.

[5]  R. Jones,et al.  Antimicrobial susceptibility tests with cefotaxime and correlation with clinical bacteriologic response. , 1982, Reviews of infectious diseases.

[6]  C. Cherubin,et al.  Comparative in Vitro Activities of Cefmenoxime (SCE-1365) and Newer Cephalosporin Derivatives of Clinical Utility , 1982, Antimicrobial Agents and Chemotherapy.

[7]  A. Tomasz Penicillin-binding proteins in bacteria. , 1982, Annals of internal medicine.

[8]  H. Neu Factors that affect the in-vitro activity of cephalosporin antibiotics. , 1982, The Journal of antimicrobial chemotherapy.

[9]  G. Dunn Ceftizoxime and other third-generation cephalosporins: structure-activity relationships. , 1982, The Journal of antimicrobial chemotherapy.

[10]  Ronald N. Jones,et al.  Cefmenoxime (SCE-1365), a new Cephalosporin: In Vitro Activity, Comparison with Other Antimicrobial Agents, Beta-Lactamase Stability, and Disk Diffusion Testing with Tentative Interpretive Criteria , 1981, Antimicrobial Agents and Chemotherapy.

[11]  H. Nakano Structure–activity relationships related to ceftizoxime (FK 749) , 1981, Medicinal research reviews (Print).

[12]  T. Eickhoff,et al.  Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative , 1981, Antimicrobial Agents and Chemotherapy.

[13]  J. Verhaegen,et al.  In vitro activity of Ro 13-9904, a new beta-lactamase-stable cephalosporin , 1981, Antimicrobial Agents and Chemotherapy.

[14]  R. Then,et al.  Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies , 1980, Antimicrobial Agents and Chemotherapy.

[15]  N. Georgopapadakou,et al.  Binding of beta-lactam antibiotics to penicillin-binding proteins of Staphylococcus aureus and Streptococcus faecalis: relation to antibacterial activity , 1980, Antimicrobial Agents and Chemotherapy.

[16]  R. Jones,et al.  Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing , 1980, Antimicrobial Agents and Chemotherapy.

[17]  H. Neu,et al.  Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin , 1980, Antimicrobial Agents and Chemotherapy.

[18]  C. Thornsberry,et al.  Antimicrobial Susceptibility Tests for Streptococcus pneumoniae , 1980 .

[19]  W. Wright,et al.  Hydrolysis of 3-acetoxymethyl cephalosporins by lysed whole blood , 1980, Antimicrobial Agents and Chemotherapy.

[20]  H. Neu,et al.  HR 756, a New Cephalosporin Active Against Gram-Positive and Gram-Negative Aerobic and Anaerobic Bacteria , 1979, Antimicrobial Agents and Chemotherapy.

[21]  H. Neu,et al.  HR 756, aNewCephalosporin Active Against Gram-Positive andGram-Negative Aerobic andAnaerobic Bacteria , 1979 .

[22]  P. Murray,et al.  Comparison of the In Vitro Activities of HR756 with Cephalothin, Cefoxitin, and Cefamandole , 1978, Antimicrobial Agents and Chemotherapy.

[23]  L. Peterson,et al.  Medium-Dependent Variation in Bactericidal Activity of Antibiotics Against Susceptible Staphylococcus aureus , 1978, Antimicrobial Agents and Chemotherapy.

[24]  H. Neu,et al.  Cefuroxime, a Beta-Lactamase-Resistant Cephalosporin with a Broad Spectrum of Gram-Positive and -Negative Activity , 1978, Antimicrobial Agents and Chemotherapy.

[25]  I. Fong,et al.  Relative Inactivation by Staphylococcus aureus of Eight Cephalosporin Antibiotics , 1976, Antimicrobial Agents and Chemotherapy.

[26]  C. O'callaghan,et al.  Cefuroxime, a New Cephalosporin Antibiotic: Activity In Vitro , 1976, Antimicrobial Agents and Chemotherapy.

[27]  K. E. Price,et al.  Effect of Assay Medium on the Antibacterial Activity of Certain Penicillins and Cephalosporins , 1973, Antimicrobial Agents and Chemotherapy.

[28]  J. Sherris,et al.  Influence of Different Media and Bloods on the Results of Diffusion Antibiotic Susceptibility Tests , 1972, Antimicrobial Agents and Chemotherapy.

[29]  J. Washington,et al.  Regression curve analysis of cephalosporin activity. , 1970, Applied microbiology.